Tuesday, October, 15, 2019 04:05:39

Acreage Pharms Ltd., a wholly-owned subsidiary of Invictus MD Strategies Corp, has reportedly signed an agreement to supply the Ontario Cannabis Retail Corporation via the Ontario Cannabis Store, with a range of superior cannabis products for the adult recreational market.

For the record, Acreage Pharms, based in Edson, Alberta is the biggest purpose-built indoor facility of Invictus which is authorized with Canada’s Cannabis Regulations and Cannabis Act. Reportedly, firm’s licensed producers include AB Laboratories Inc. in Hamilton, Ontario and 0989561 B.C Ltd. in Delta, British Columbia.

George E. Kveton, President and CEO of Invictus, stated that the company is thrilled to introduce Canada’s largest market to its premium cannabis products through the OCS. He further mentioned that Invictus has been delivering to customers in Alberta and BC since the use of adult recreational cannabis was legalized in October 2018. Now the first-time consumers in Ontario will get to experience what Invictus has to offer, Kveton added.

According to an official release by Invictus, the firm’s product portfolio is estimated to grow in 2019 with a variety of new oils, strains, and concentrates depending on regulatory permissions. In August 2018, Acreage Pharms attained its extraction license for the production of cannabis oil and would continue to work with Health Canada to receive its sales license for oil products. Moreover, Invictus is also an active participant in discussions with the Government of Canada over the proposed regulations governing edibles, which are anticipated to be legalized in Canada in the fourth quarter of 2019, the press release stated.

For the record, the agreement to supply adult recreational cannabis in Ontario is Invictus’ fourth agreement in Canada following British Columbia, Alberta, and Saskatchewan. Reportedly, the company has also signed its first international agreement with Germany based firm Deutsche Medizinalcannabis GmbH for the supply and distribution of medical cannabis.